首页> 外国专利> CELL FOR GENE THERAPY OF LCAT DEFICIENCY, AND REPLICATION-DEFICIENT RETROVIRUS VECTOR AND PLASMID FOR USE IN THE PRODUCTION OF THE CELL

CELL FOR GENE THERAPY OF LCAT DEFICIENCY, AND REPLICATION-DEFICIENT RETROVIRUS VECTOR AND PLASMID FOR USE IN THE PRODUCTION OF THE CELL

机译:用于LCAT缺陷基因治疗的细胞,以及复制缺陷型逆转录病毒和质粒用于细胞生产

摘要

Disclosed is a replication-deficient retrovirus vector carrying an LCAT-encoding nucleotide, which enables the LCAT-encoding nucleotide (an exogenous gene) to be expressed in a target cell with efficiency, and which can be used for the production of a cell for gene therapy to be administered to a patient. Also disclosed is a plasmid which can be used for the production of the retrovirus vector. Specifically disclosed is a plasmid for use in the production of a replication-deficient retrovirus vector, which has the 5'-LTR sequence and the 3'-LTR sequence derived from a retrovirus, an LCAT-encoding nucleotide sequence which is inserted betweenthe 5'-LTR sequence and the 3'-LTR sequence as an exogenous gene, and a Kozak's consensus sequence and a packaging signal sequence for the retrovirus both linked to the 5'-end of the LCAT-encoding nucleotide sequence.
机译:公开了一种携带LCAT编码核苷酸的复制缺陷型逆转录病毒载体,该载体可使LCAT编码核苷酸(外源基因)在靶细胞中高效表达,并可用于生产基因细胞对患者进行的治疗。还公开了可用于生产逆转录病毒载体的质粒。具体公开了用于生产复制缺陷型逆转录病毒载体的质粒,其具有5'-LTR序列和衍生自逆转录病毒的3'-LTR序列,LCAT编码核苷酸序列插入5'之间-LTR序列和作为外源基因的3'-LTR序列,以及逆转录病毒的Kozak共有序列和包装信号序列均与编码LCAT的核苷酸序列的5'-末端相连。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号